HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Min, W.-K. Articles by Huh, J. W. Search for Related Content PubMed PubMed Citation Articles by Min, W.-K. Articles by Huh, J. W. Related Collections Evidence Based Laboratory Medicine and Test Utilization Lipids, Lipoproteins, and Cardiovascular Risk Factors

Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease

Department of Clinical Pathology, University of Ulsan College of Medicine and Asan Medical Center, 388–1 PoongNap-Dong SongPa-Gu, Seoul 138–736 Korea.
wkmin{at}amc.ulsan.ac.kr

This study investigated whether lipoprotein(a) [Lp(a)] is an acute-phase reactant that can cause important bias in risk factor analysis for coronary heart disease among patients with an acute-phase response (APR patients). To determine whether serum Lp(a) concentrations increase among APR patients, we compared the Lp(a) concentrations and apolipoprotein(a) [apo(a)] phenotypes of 100 controls with those of a random sampling of 100 APR patients. Serum Lp(a) concentration was measured by ELISA; Lp(a) phenotyping was performed by electrophoresis on sodium dodecyl sulfate–polyacrylamide gel. Lp(a) was significantly (P <0.0001) higher among APR patients (mean ± SD 0.300 ± 0.284 g/L) than among controls (0.118 ± 0.193 g/L) even though the distribution of apo(a) phenotypes did not differ significantly. The 100 APR patients were grouped into 4 categories: 48 patients with infections, 25 postoperative patients, 17 patients with tumors, and 10 patients with other diseases, all of whom showed substantially higher Lp(a) values than did the controls. For the S5, S4S5, S5S5, and S4 phenotypes, the mean concentrations of serum Lp(a) were substantially higher among the APR patients.

The following articles in journals at HighWire Press have cited this article:

				C. H. Saely, T. Marte, H. Drexel, C. P. Kovesdy, A. A. Ariyo, R. P. Tracy, and C. Thach Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly N. Engl. J. Med., March 11, 2004; 350(11): 1150 - 1152. [Full Text] [PDF]

				D J Byrne, I A Jagroop, H E Montgomery, M Thomas, D P Mikhailidis, N G Milton, and A F Winder Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk J. Clin. Pathol., April 1, 2002; 55(4): 280 - 285. [Abstract] [Full Text] [PDF]

				C. A. Glader, B. Stegmayr, J. Boman, H. Stenlund, L. Weinehall, G. Hallmans, and G. H. Dahlen Chlamydia pneumoniae Antibodies and High Lipoprotein(a) Levels Do Not Predict Ischemic Cerebral Infarctions : Results From a Nested Case-Control Study in Northern Sweden Stroke, October 1, 1999; 30(10): 2013 - 2018. [Abstract] [Full Text] [PDF]